- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04686695
Transcutaneous Auricular Vagus Nerve Stimulation Treatment on Meniere Disease
Transcutaneous Auricular Vagus Nerve Stimulation for the Treatment of Meniere Disease: a Pilot Study
Objective: To evaluate the effect of Transcutaneous auricular vagus nerve stimulation for the patients Meniere disease.
Methods: We accrued 25 patients at Beijing TongRen Hospital. All treatments were self-administered by the patients at home after training at the hospital. Patients completed questionnaires at baseline and after 4 weeks, 8 weeks, 12 weeks.
Tinnitus Handicap Inventory (THI), Dizziness Handicap Inventory (DHI), Pure Tone Audiometry, visual scale of ear stuffiness and SF-36 were performed to evaluate the therapeutic effects.
A difference of P < 0.05 was considered statistically significant.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Beijing, China
- Beijing Tongren Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age >=18 and Age <=70.
- Clinical diagnosis of meniere disease.
Exclusion Criteria:
- History of depression, tumors, thyroid disease, diabetes, cardiac diseases.
- History of Otorhinolaryngology surgery.
- Pregnant or lactating women.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Transcutaneous Auricular Vagus Nerve Stimulation
|
taVNS was applied using a Huatuo stimulator (SDZ-IIB) developed by Suzhou manufacture of Medical Device and Material.
Stimulation parameters was 1 mA of electrical current at a frequency of 20 Hz with pulse duration ≤ 1 ms, for 30min,administered twice daily.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean change from Baseline in the Tinnitus Handicap Inventory (THI) rating scale at 12 Weeks
Time Frame: Day 0 and postintervention at Week 12
|
Tinnitus Handicap Inventory (THI) to measure the subjective tinnitus symptoms.
Tinnitus Handicap Inventory (THI) to measure the subjective tinnitus symptoms
|
Day 0 and postintervention at Week 12
|
Mean change from Baseline in the Dizziness Handicap Inventory (DHI) at 12 Weeks
Time Frame: Day 0 and postintervention at Week 12
|
DHI to measure the subjective dizziness symptoms.
|
Day 0 and postintervention at Week 12
|
Mean change from Baseline in the Pure Tone Audiometry at 12 Weeks
Time Frame: Day 0 and postintervention at Week 12
|
Pure Tone Audiometry to measure the audition.
|
Day 0 and postintervention at Week 12
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean change from Baseline in the 36-items Short Form(SF-36) at 12 Weeks
Time Frame: Day 0 and postintervention at Week 12
|
SF-36 to measure quality of life
|
Day 0 and postintervention at Week 12
|
Mean change from Baseline in the visual scale of ear stuffiness at 12 Weeks
Time Frame: Day 0 and postintervention at Week 12
|
Visual scale to measure the subjective ear stuffiness symptoms
|
Day 0 and postintervention at Week 12
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- taVNS-MD-2020
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Meniere Disease
-
Norfolk and Norwich University Hospitals NHS Foundation...University of East Anglia; Ménière's SocietyCompleted
-
Medical University of South CarolinaAmerican Hearing Research Foundation; Cures within Reach FoundationCompletedMeniere DiseaseUnited States
-
Otonomy, Inc.Terminated
-
Beijing Tongren HospitalCompleted
-
Otonomy, Inc.Terminated
-
Alvogen KoreaCompleted
-
Ludwig-Maximilians - University of MunichCompletedMénière's DiseaseGermany
-
University Hospital, BordeauxCompleted
-
University of California, San DiegoAmerican Society of Head and Neck RadiologyCompletedMeniere's DiseaseUnited States
-
Osaka UniversityCompletedMeniere's DiseaseJapan
Clinical Trials on taVNS
-
Qiuyou XieBrainClos Co., LTD.; Zhuhai Fudan Innovation InstituteRecruitingStroke | Upper Extremity DysfunctionChina
-
University of FloridaNot yet recruiting
-
University of LiegeRecruitingMinimally Conscious State | Vegetative State | Consciousness DisorderBelgium
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)Completed
-
Federal University of São PauloUnknown
-
Tongji UniversityShanghai East HospitalCompletedAbdominal Pain | Constipation-predominant Irritable Bowel SyndromeChina
-
Medical University of South CarolinaCompleted
-
Burrell College of Osteopathic MedicineNot yet recruitingAtrial Fibrillation, PersistentUnited States
-
Possover International Medical Center AGNot yet recruitingCentral Nervous System Diseases | Nervous System Diseases | Movement Disorders | Trauma, Nervous System | Spinal Cord Diseases | Spinal Cord Injuries
-
Spaulding Rehabilitation HospitalNot yet recruiting